- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Psoriatic arthritis
- Meeting Date: November 2020
- Public Summary Document (PSD) November 2020 PBAC Meeting - (PDF 1390KB)
- Public Summary Document (PSD) November 2020 PBAC Meeting - (Word 124KB)
Guselkumab – November 2020
Guselkumab: Injection 100 mg in 1 mL single use pre-filled syringe, Injection 100 mg in 1 mL single use pre-filled pen; Tremfya®
Last updated
5 March 2021